Qube Research & Technologies LTD Rx Sight, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Rx Sight, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 152,902 shares of RXST stock, worth $7.08 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
152,902
Previous 188,453
18.86%
Holding current value
$7.08 Million
Previous $9.72 Million
5.35%
% of portfolio
0.01%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding RXST
# of Institutions
231Shares Held
32.4MCall Options Held
57.8KPut Options Held
12.5K-
Ra Capital Management, L.P. Boston, MA3.69MShares$171 Million3.35% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$111 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.01MShares$93 Million0.0% of portfolio
-
Lord, Abbett & Co. LLC Jersey City, NJ1.74MShares$80.4 Million0.34% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.17MShares$54.2 Million0.09% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $1.28B
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...